Protagenic Therapeutics, Inc.

NasdaqCM:PTIX Stock Report

Market Cap: US$7.0m

Protagenic Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.3yrs

Recent management updates

Recent updates


CEO

Protagenic Therapeutics has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Garo Armen
Co-Founder & Executive Chairman of the Boardno datano data16.56%
$ 1.2m
Robert Stein
Chief Medical Officer & Director8.2yrsno data0%
$ 0
Timothy Wright
Independent Director1.4yrsno datano data
Brian Corvese
Independent Director6.8yrsUS$118.75k0%
$ 0
Khalil Barrage
Independent Directorno dataUS$243.75k3.4%
$ 236.7k
Jennifer Buell
Independent Director3.8yrsno data0%
$ 0

5.3yrs

Average Tenure

65yo

Average Age

Experienced Board: PTIX's board of directors are considered experienced (5.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.